Valiant Laboratories Limited is an Indian pharmaceutical company that manufactures Active Pharmaceutical Ingredients (APIs) and bulk drugs.
Their main focus is on the production of paracetamol.
The company was incorporated in 1980 and is registered with the Registrar of Companies in Mumbai.
Their authorized share capital is Rs. 230,000,000 and their paid up capital is Rs. 162,800,000.
Valiant Laboratories Limited is currently offering an Initial Public Offering (IPO).
The price band for the IPO is Rs 133-140 per share. The minimum application size for retail investors is Rs 14,700 (105 shares) and the maximum is Rs 1,91,100 (1,365 shares).
The company has set a T+3 timeline for the listing of shares, which will be October 9. The finalization of share allotment will likely be completed on October 5.
The company’s Managing Director is Shri Santosh S. Vora. Their address is 104,Udyog Kshetra, Mulund Goregaon Link Road, Mulund West, Mumbai -400080. Their phone number is +91 2249712001.
Valiant Laboratories IPO Timeline
| Particular | Date |
| IPO Open Date | 27 Sep 2023 |
| IPO Close Date | 03 Oct 2023 |
| Allotment Date | 05 Oct 2023 |
| IPO Listing Date | 06 Oct 2023 |
Valiant Laboratories IPO Details
| Issue Type | Book Built Issue IPO |
| Face Value | Rs. 10 Per Equity Share |
| IPO Price | Rs. 133 to Rs. 140 Per Equity Share |
| Market Lot | 105 Share |
| ISIN Code | |
| Listing At | NSE & BSE |
| Issue Size | Approx. Rs. 152.46 Crore. |
Valiant Laboratories IPO Lot Size
| Application | Lots | Shares | Amount |
| Minimum | 1 | 105 | Rs. 14700 |
| Maximum | 13 | 1365 | Rs. 191100 |
| Small HNI (Minimum) | 14 | 1470 | Rs. 205800 |
| Big HNI (Minimum) | 68 | 7245 | Rs. 1014300 |
Valiant Laboratories IPO Allotment Status
Company Financials:
| Particular | 31 March 2023 | 31 March 2022 | 31 March 2021 |
| Total Assets | 212.76 | 181.81 | 106.31 |
| Total Revenue | 338.77 | 293.47 | 183.78 |
| Profit After Tax | 29.00 | 27.50 | 30.59 |
Company Promoters:
Shantilal Shivji Vora, Santosh Shantilal Vora, and Dhanvallabh Ventures LLP (DVL) are the company’s promoters.
Purpose of the Issue
- Investment in its wholly-owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL) for part-financing its capital expenditure requirements in relation to the setting up of a manufacturing facility for specialty chemicals at Saykha Industrial Area, Bharuch, Bharuch, Gujarat (Proposed Facility).
- Investment in VASPL for funding its working capital requirements.
- General corporate purposes.
Registrar & Company Details
| Company Contact Information | IPO Registrar |
| Valiant Laboratories Limited 104,Udyog Kshetra, Mulund Goregaon Link Road, Mulund West, Mumbai -400080 Phone: +91 2249712001 Email: complianceofficer@valiantlabs.in Website: https://valiantlabs.in/ | Link Intime India Private Ltd Phone: +91-22-4918 6270 Email: valiantlaboratories.ipo@linkintime.co.in Website: https://linkintime.co.in/mipo/ipoallotment.html |
